Advances of safety of antithrombotic therapy in patients with chronic kidney disease plus atrial fibrillation after percutaneous coronary intervention

• Główni autorzy: Jia-xuan Ning (Autor), Nan Ye (Autor), Guo-qin Wang (Autor), Wei-jing Bian (Autor), Hong Cheng (Autor)
• Format: Książka
• Wydane: Editorial Department of Journal of Clinical Nephrology, 2024-09-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Patients of atrial fibrillation （AF） are prone to develop secondary coronary artery disease （CAD） and acute coronary syndrome （ACS） or percutaneous coronary intervention （PCI） is required. Anticoagulation and antiplatelet therapy are a gold standard for AF patients with post-PCI. However, there is a...